Bahrain has approved the Pfizer COVID-19 vaccine for emergency use for children aged between 5 and 11 years, the government media office said on Tuesday.
The decision came after a study involving 3,100 children aged between 5 and 11 were administered with the vaccine found it to be 90.7 per cent effecting in that age group, said the statement, citing the National Health Regulatory Authority.
None of the children involved in the study showed severe side effects, it added.
Bahrain will be supplied with doses from the manufacturer for the 5-11 age group from the start of 2022, it said.
Rubio says Israeli strike on Gaza didn't violate ceasefire
Trump heads to Tokyo for trade, security talks before Xi summit
Two climbers die in Nepal after expeditions to Ama Dablam mountain
India evacuates tens of thousands as Cyclone Montha gains strength
